Fair funding for mental health: putting parity into practice: Briefing – Institute for Public Policy Research

The NHS is currently in the process of authoring a long-term plan that will set out what it wants to achieve with additional funding and how this funding will be allocated. This Institute for Public Policy Research briefing argues that

How Should Health Policy Respond To The Growing Challenge Of Multimorbidity?: We need patient-centred care, with more emphasis on generalist rather than specialist care and better integration between general practice, hospitals and social care: (Policy Report 39) – University of Bristol, Policy Bristol

The number of people with multiple long-term conditions, known as multimorbidity, is rising internationally, putting increased pressure on health care systems, including the NHS. Researchers from the 3D Study – the largest ever trial of a person-centred approach to caring

Should the NHS become more of a lifestyle coach to tackle unhealthy living? – Healthwatch

Healthwatch poll of over 2000 UK adults about their confidence in the ability of services to meet their needs today and in 20-30 years’ time.  Positively, 61% of respondents are confident that NHS and social care services are currently able

End of life care: strengthening choice: An inquiry report by the All-Party Parliamentary Group (APPG) for Children Who Need Palliative Care – All-Party Parliamentary Group (APPG) for Children Who Need Palliative Care

Report that highlights five areas of particular concern, where many children and their families have limited access to: children’s palliative care out of hours and at weekends short breaks for respite age-appropriate palliative care and smooth transitions to adult services

Progress of the Five Year Forward View for Mental Health: On the road to parity – All-Party Parliamentary Group on Mental Health

All-Party Parliamentary Group on Mental Health report of an in depth inquiry into the progress of the government’s mental health strategy, the Five Year Forward View for Mental Health. The findings can be split into three main themes: investing in

Pharmacy and Dispensing Practice Q&A regarding EpiPen and EpiPen Junior Supply issue – NHS England

This Q&A has been developed for pharmacies and dispensing GP practices about the EpiPen and EpiPen Junior Supply issue.  

Young People and Cannabis use in Liverpool – Liverpool John Moores University Centre for Public Health

This study investigated cannabis use in young people recruited from Liverpool City Centre aged between 16-25 years and who were not in contact with treatment services. The research aimed to identify patterns of young people’s cannabis use and to investigate

Younger drug users assessed by DIP teams in non-intensive areas; characteristics and implications for service delivery – Liverpool John Moores University Centre for Public Health

This report examines the characteristics of clients assessed by DIP teams in 31 non-intensive D(A)AT areas across England in 2006/7. It focuses upon significant differences between clients under 25 and their older counterparts. The implications for service delivery are discussed.

Burosumab for treating X-linked hypophosphataemia in children and young people: Highly specialised technologies guidance [HST8] – NICE

Evidence-based recommendations on burosumab (Crysvita) for X‑linked hypophosphataemia in children and young people. Burosumab is recommended, within its marketing authorisation, for treating X‑linked hypophosphataemia (XLH) with radiographic evidence of bone disease in children aged 1 year and over, and in

Renal replacement therapy and conservative management: NICE guideline [NG107] – NICE

This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5. It aims to improve quality of life by making recommendations on planning, starting and switching treatments, and coordinating

Decision-making and mental capacity: NICE guideline [NG108] – NICE

This guideline covers decision-making in people 16 years and over who may lack capacity now or in the future. It aims to help health and social care practitioners support people to make their own decisions where they have the capacity

Renal replacement therapy services for adults: Quality standard [QS72] – NICE

This quality standard covers renal replacement therapy services for adults with kidney failure. It includes treatment options, such as dialysis and kidney transplant. It describes high-quality care in priority areas for improvement.

Estimating diversion ratios of hospital mergers: Economics Working Paper – Competition and Markets Authority

Understanding patient choice is vital in assessing the closeness of competition between hospitals. The standard technique used in the UK is to estimate substitution patterns based on historical GP referrals. This paper compares the results of the ‘GP referral’ methodology to a demand

State Of Child Health: Short report series: Child health in 2030 in England: comparisons with other wealthy countries – Royal College of Paediatrics and Child Health

This report uses long term historical data on key children and young people (CYP) health outcomes and various projection modelling methods to estimate CYP outcomes in 2030 in England compared with other wealthy European and western countries. The accompanying recommendations

Cabozantinib for untreated advanced renal cell carcinoma: Technology appraisal guidance [TA542] – NICE

Evidence-based recommendations on cabozantinib (Cabometyx) for untreated advanced renal cell carcinoma in adults. Cabozantinib is recommended, within its marketing authorisation, for adults with untreated advanced renal cell carcinoma that is intermediate‑ or poor‑risk as defined in the International Metastatic Renal

Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs: Technology appraisal guidance [TA543] – NICE

Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis in adults after inadequate response to DMARDs. It recommends:  Tofacitinib, with methotrexate, is recommended as an option for treating active psoriatic arthritis in adults, only if: it is used as

Price increases for generic medications: Sixty-Second Report of Session 2017–19: Report, together with formal minutes relating to the report – House of Commons Committee of Public Accounts

During 2017, the prices of certain generic medicines purchased by community pharmacies for the NHS increased unexpectedly, affecting an unusually high number of medicines. Although the Department of Health & Social Care (the Department) and its arms-length bodies took action

Tuberculosis in London: Annual review (2012 data): Data from 1999 to 2012 – Public Health England

Annual regional reports for the recent epidemiology of TB. This report describes the recent epidemiology of TB in London, providing an update on local trends, identifying areas of high burden of disease, at-risk population groups, and opportunities for interventions and prevention of future

Tuberculosis in London: Annual review (2013 data): Data from 1999 to 2013 – Public Health England

Annual regional reports for the recent epidemiology of TB. This report describes the recent epidemiology of TB in London, providing an update on local trends, identifying areas of high burden of disease, at-risk population groups, and opportunities for interventions and prevention of future